Renewal of the Advisory Committee on the Maternal, Infant and Early Childhood Home Visiting Program Evaluation, 70565-70566 [2013-28324]
Download as PDF
<![CDATA[
70565
Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices
MSAs were chosen based on having
high AIDS prevalence. Persons at risk
for HIV infection to be interviewed for
NHBS include men who have sex with
men (MSM), injecting drug users (IDU),
and heterosexuals at increased risk of
HIV (HET). A brief screening interview
will be used to determine eligibility for
participation in the behavioral
assessment.
The data from the behavioral
assessment will provide estimates of (1)
behavior related to the risk of HIV and
other sexually transmitted diseases, (2)
prior testing for HIV, (3) and use of HIV
prevention services.
All persons interviewed will also be
offered an HIV test, and will participate
in a pre-test counseling session. No
other federal agency systematically
collects this type of information from
persons at risk for HIV infection. These
data have substantial impact on
prevention program development and
monitoring at the local, state, and
national levels.
CDC estimates that NHBS will
involve, per year in each of the 25
MSAs, eligibility screening for 50 to 200
persons and eligibility screening plus
the behavioral assessment with 500
eligible respondents, resulting in a total
of 37,500 eligible survey respondents
and 7,500 ineligible screened persons
during a 3-year period. Data collection
will rotate such that interviews will be
conducted among one group per year:
MSM in year 1, IDU in year 2, and HET
in year 3. The type of data collected for
each group will vary slightly due to
different sampling methods and risk
characteristics of the group.
Participation of respondents is
voluntary and there is no cost to the
respondents other than their time.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Form
Persons Screened ..................................
Eligible Participants: ...............................
Eligible Participants: ...............................
Eligible Participant ..................................
Peer Recruiters: ......................................
Average
burden per
response
(hours)
Total
burden
(in hours)
15,000
4,167
4,167
4,167
4,167
1
1
1
1
1
5/60
30/60
54/60
39/60
2/60
1,250
2,084
3,750
2,709
139
........................
........................
....................
9,932
Eligibility Screener ..................................
Behavioral Assessment MSM ................
Behavioral Assessment IDU ...................
Behavioral Assessment HET ..................
Recruiter Debriefing ................................
Total Annualized Burden ........................
.................................................................
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–28280 Filed 11–25–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Health Resources and Services
Administration
Renewal of the Advisory Committee on
the Maternal, Infant and Early
Childhood Home Visiting Program
Evaluation
ACTION:
emcdonald on DSK67QTVN1PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Respondent
Notice.
Authority: Section 511(g)(1) of Title V of
the Social Security Act (42 U.S.C. 711 et
seq.), as amended by Section 2951 of the
Patient Protection and Affordable Care Act of
2010 (Pub.L. 111–148). The Committee is
governed by provisions of Public Law 92–
463, as amended, (5 U.S.C. App.2), which
sets forth standards for the formation and use
of advisory committees.
ACF and HRSA announce the
renewal of the Advisory Committee on
the Maternal, Infant and Early
SUMMARY:
VerDate Mar<15>2010
18:04 Nov 25, 2013
Jkt 232001
Childhood Home Visiting Program
Evaluation to provide advice to the
Secretary of Health and Human Services
(‘‘the Secretary’’) on the design, plan,
progress, and findings of the evaluation
required under the Act.
FOR FURTHER INFORMATION CONTACT:
T’Pring Westbrook, Administration for
Children and Families;
tpring.westbrook@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: Section
511(g) of the Affordable Care Act of
2010 mandates an Advisory Committee
to review, and make recommendations
on, the design and plan for the
evaluation required under the Act. To
comply with the authorizing directive
and guidelines under the Federal
Advisory Committee Act (FACA), a
charter has been filed with the
Committee Management Secretariat in
the General Services Administration
(GSA), the appropriate committees in
the Senate and U.S. House of
Representatives, and the Library of
Congress to establish the Advisory
Board as a non-discretionary federal
advisory committee. The charter was
filed on January 27, 2013.
Objectives and Scope of Activities
The purpose of the Committee is to
provide advice and make
recommendations to the Secretary of
Health and Human Services, through
the Assistant Secretary, ACF and
Administrator, HRSA, with respect to
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
the design, plan, progress and results of
the evaluation.
Membership and Designation
The Committee shall consist of up to
25 members appointed by the Secretary.
Members shall be experts in the areas of
program evaluation and research,
education, and early childhood
development. Members shall be
appointed as Special Government
Employees. The committee shall also
include ex-officio members representing
ACF, HRSA and other agencies of the
federal government designated by the
Secretary as ex-officio members. The
ACF Assistant Secretary and HRSA
Administrator each shall recommend
nominees for Co-Chairs of the
Committee.
Members shall be invited to serve
from the date of appointment through
March 31, 2015; such terms are
contingent upon the renewal of the
Committee by appropriate action prior
to its termination.
Administrative Management and
Support
Coordination, management, and
operational services shall be provided
by ACF, with assistance from HRSA.
A copy of the Committee charter can
be obtained from the designated
contacts or by accessing the FACA
database that is maintained by the GSA
Committee Management Secretariat. The
E:\FR\FM\26NON1.SGM
26NON1
70566
Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices
Dated: November 20, 2013.
Bernadette Dunahm,
Director, Center for Veterinary Medicine.
Web site for the FACA database is
https://fido.gov/facadatabase/.
Naomi Goldstein,
Director, Office of Planning, Research, and
Evaluation, ACF.
Rebecca Slifkin,
Director, Office of Planning, Analysis and
Evaluation, HRSA.
[FR Doc. 2013–28255 Filed 11–25–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–28324 Filed 11–25–13; 8:45 am]
National Institutes of Health
BILLING CODE 4184–22–P
Office of the Director, National
Institutes of Health; Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0002]
Withdrawal of Approval of New Animal
Drug Applications; Arsanilic Acid
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is withdrawing
approval of a new animal drug
application (NADA) for an arsanilic acid
Type A medicated article at the
sponsor’s request because the product is
no longer manufactured or marketed.
SUMMARY:
Withdrawal of approval is
effective December 6, 2013.
DATES:
John
Bartkowiak, Center for Veterinary
Medicine (HFV–212), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–276–9079,
john.bartkowiak@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Fleming
Laboratories, Inc., P.O. Box 34384,
Charlotte, NC 28234 has requested that
FDA withdraw approval of NADA 008–
019 for PRO–GEN (arsanilic acid) Type
A medicated article because the
product, used to manufacture Type B
and Type C medicated feeds, is no
longer manufactured or marketed.
Therefore, under authority delegated
to the Commissioner of Food and Drugs
and redelegated to the Center for
Veterinary Medicine, and in accordance
with § 514.116 Notice of withdrawal of
approval of application (21 CFR
514.116), notice is given that approval
of NADA 008–019, and all supplements
and amendments thereto, is hereby
withdrawn.
Elsewhere in this issue of the Federal
Register, FDA is amending the animal
drug regulations to reflect the voluntary
withdrawal of approval of this
application.
emcdonald on DSK67QTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
18:04 Nov 25, 2013
Jkt 232001
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a stakeholder meeting
hosted by the NIH Scientific
Management Review Board (SMRB).
The SMRB’s Working Group on
Approaches to Assess the Value of
Biomedical Research Supported by NIH
will present their findings and
conclusions regarding optimal
approaches to assessing the value of
biomedical research supported by the
NIH.
The NIH Reform Act of 2006 (Pub. L.
109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH
including adding, removing, or
transferring the functions of such offices
or establishing or terminating such
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the SMRB is to advise appropriate
HHS and NIH officials on the use of
these organizational authorities and
identify the reasons underlying the
recommendations.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Scientific
Management Review Board (SMRB).
Date: December 18, 2013.
Time: 10:00 a.m. to 12:00 p.m. (EST).
Agenda: The teleconference will focus on
the findings and recommendations of the
Working Group on Approaches to Assess the
Value of Biomedical Research Supported by
NIH. The full Board will review and vote on
the draft report from the Working Group.
SMRB members will also be presented with
a new charge regarding science, technology,
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
engineering, and mathematics (STEM)
education. Time will be allotted on the
agenda for public comment. To sign up for
public comment, please submit your name
and affiliation to the contact person listed
below by December 17, 2013. Sign-up will be
restricted to one sign-up per person. In the
event that time does not allow for all those
interested to present oral comments, any
interested person may file written comments
with the committee by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The toll-free number to participate in the
teleconference is 800–369–1872, and the
passcode will be 7887272.
Place: National Institutes of Health, Office
of the Director, NIH, Office of Science Policy,
6705 Rockledge Drive, Suite 750, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Juanita Marner, Office of
Science Policy, Office of the Director, NIH,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892,
smrb@mail.nih.gov, (301) 435–1770.
The draft meeting agenda and other
information about the SMRB will be available
at https://smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS).
Dated: November 20, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–28266 Filed 11–25–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
E:\FR\FM\26NON1.SGM
26NON1
]]>Agencies
[Federal Register Volume 78, Number 228 (Tuesday, November 26, 2013)]
[Notices]
[Pages 70565-70566]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28324]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Health Resources and Services Administration
Renewal of the Advisory Committee on the Maternal, Infant and
Early Childhood Home Visiting Program Evaluation
ACTION: Notice.
-----------------------------------------------------------------------
Authority: Section 511(g)(1) of Title V of the Social Security
Act (42 U.S.C. 711 et seq.), as amended by Section 2951 of the
Patient Protection and Affordable Care Act of 2010 (Pub.L. 111-148).
The Committee is governed by provisions of Public Law 92-463, as
amended, (5 U.S.C. App.2), which sets forth standards for the
formation and use of advisory committees.
SUMMARY: ACF and HRSA announce the renewal of the Advisory Committee on
the Maternal, Infant and Early Childhood Home Visiting Program
Evaluation to provide advice to the Secretary of Health and Human
Services (``the Secretary'') on the design, plan, progress, and
findings of the evaluation required under the Act.
FOR FURTHER INFORMATION CONTACT: T'Pring Westbrook, Administration for
Children and Families; tpring.westbrook@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: Section 511(g) of the Affordable Care Act of
2010 mandates an Advisory Committee to review, and make recommendations
on, the design and plan for the evaluation required under the Act. To
comply with the authorizing directive and guidelines under the Federal
Advisory Committee Act (FACA), a charter has been filed with the
Committee Management Secretariat in the General Services Administration
(GSA), the appropriate committees in the Senate and U.S. House of
Representatives, and the Library of Congress to establish the Advisory
Board as a non-discretionary federal advisory committee. The charter
was filed on January 27, 2013.
Objectives and Scope of Activities
The purpose of the Committee is to provide advice and make
recommendations to the Secretary of Health and Human Services, through
the Assistant Secretary, ACF and Administrator, HRSA, with respect to
the design, plan, progress and results of the evaluation.
Membership and Designation
The Committee shall consist of up to 25 members appointed by the
Secretary. Members shall be experts in the areas of program evaluation
and research, education, and early childhood development. Members shall
be appointed as Special Government Employees. The committee shall also
include ex-officio members representing ACF, HRSA and other agencies of
the federal government designated by the Secretary as ex-officio
members. The ACF Assistant Secretary and HRSA Administrator each shall
recommend nominees for Co-Chairs of the Committee.
Members shall be invited to serve from the date of appointment
through March 31, 2015; such terms are contingent upon the renewal of
the Committee by appropriate action prior to its termination.
Administrative Management and Support
Coordination, management, and operational services shall be
provided by ACF, with assistance from HRSA.
A copy of the Committee charter can be obtained from the designated
contacts or by accessing the FACA database that is maintained by the
GSA Committee Management Secretariat. The
[[Page 70566]]
Web site for the FACA database is https://fido.gov/facadatabase/.
Naomi Goldstein,
Director, Office of Planning, Research, and Evaluation, ACF.
Rebecca Slifkin,
Director, Office of Planning, Analysis and Evaluation, HRSA.
[FR Doc. 2013-28324 Filed 11-25-13; 8:45 am]
BILLING CODE 4184-22-P
